MedPath

Sitaform

Brand Name: Sitaform

Generic Name: Sitagliptin (as phosphate monohydrate) + Metformin Hydrochloride

Active
Registration Number

DRP-12238

Dosage Form

Film Coated Tablet

Issuance Date

July 1, 2022

Expiry Date

July 1, 2027

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength50 mg/500 mg
PackagingAlu/Alu Blister Pack x 10's (Box of 30's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Blood Glucose Lowering Drug
A
Application
Initial
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

Sitagliptin (as phosphate monohydrate)Active
Monograph: sitagliptin (as phosphate monohydrate)
Metformin HydrochlorideActive
Monograph: Metformin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform